Navigator

      Support By : Li-lab

Drug-Pathway
DRUGs and PATHWAYs
PATHWAY_NAME REACTOME_ID KEGG_ID DRUG_NAME PUBCHEM_CID Datasource
Hepatocellular carcinoma #N/A #N/A Sorafenib 216239 kegg
Hepatocellular carcinoma #N/A #N/A Regorafenib hydrate 24768591 kegg
Hepatocellular carcinoma #N/A #N/A Regorafenib 11167602 kegg
Gastric cancer #N/A #N/A Trastuzumab None kegg
Central carbon metabolism in cancer #N/A #N/A Lonidamine 39562 kegg
Central carbon metabolism in cancer #N/A #N/A Ivosidenib 71657455 kegg
Central carbon metabolism in cancer #N/A #N/A Pralsetinib 129073603 kegg
Central carbon metabolism in cancer #N/A #N/A Selpercatinib 134436906 kegg
Central carbon metabolism in cancer #N/A #N/A Telaglenastat 71577426 kegg
Central carbon metabolism in cancer #N/A #N/A Telaglenastat hydrochloride 118867525 kegg
Central carbon metabolism in cancer #N/A #N/A Pralsetinib hydrate None kegg
Central carbon metabolism in cancer #N/A #N/A Nanvuranlat hydrochloride hydrate 171904561 kegg
Central carbon metabolism in cancer #N/A #N/A Olutasidenib 118955396 kegg
Central carbon metabolism in cancer #N/A #N/A Bezuclastinib 75593308 kegg
Central carbon metabolism in cancer #N/A #N/A Crelosidenib 135125140 kegg
Central carbon metabolism in cancer #N/A #N/A Crelosidenib gentisate 169490794 kegg
PD-L1 expression and PD-1 checkpoint pathway in cancer #N/A #N/A Nivolumab None kegg
PD-L1 expression and PD-1 checkpoint pathway in cancer #N/A #N/A Pidilizumab None kegg
PD-L1 expression and PD-1 checkpoint pathway in cancer #N/A #N/A Pembrolizumab None kegg
PD-L1 expression and PD-1 checkpoint pathway in cancer #N/A #N/A Atezolizumab None kegg